Bayer increases its donations of medications for #ebola
patients to a total value of more than EUR 3.7 million#Bayer
is expanding its aid donations for ebola patients in Liberia and Sierra Leone. The company is supplementing its previous donation of medications with a further delivery of an antibiotic to a value of EUR 1.15 million. This medication does not treat the ebola infection itself, but can be used for life-threatening secondary bacterial infections. Distribution to two clinics in Monrovia, the capital city of Liberia, and health centers in the surrounding area will be carried out through “action medeor – Das Medikamentenhilfswerk,” the largest Germany-based aid organization specializing in medicines. Bayer has already donated an antibiotic in various dosages and modes of administration to a value of approximately EUR 2.57 million to treat patients infected with the ebola virus free of charge in Sierra Leone and Liberia through the American organization “Direct Relief.” This donation of medication for treating African ebola patients with a total value of over EUR 3.7 million is one of the largest in Bayer’s history.